Products of other enterprises
Description
Composition - 1 ml:
Composition - 1 mL:Active ingredient - Virus rabiei inactivatum, strain SAD Vnukovo-32min. 2-4 IUExcipients - Nutrimentum MEM- Algedratum- Thiomersalum
Cell culture used for vaccine production: BHK-21 derived from hamster kidney
ATC classification:
Q15AA Veterinary vaccines
Pharmacotherapeutical group:
97 Veterinary immunopreparation
Pharmacological properties:
After application into the body of the vaccinated individual, the antigen present in the vaccine is recognized as an extraneous substances and a number of defensive mechanisms is activated in the organism (macrophagus, opsonins, interleucines, B lymfocytes etc.), in consequence of which creation of specific antibodies against the antigen determinants, contained in the vaccine, occurs. The said mechanisms are supposed to prevent from consequent development of infection after infectation.
The animals are vaccinated from 3 months of age. The protective immunity starts 14 days after immunization. The animals that were vaccinated before they reached 3 months of age must be re-vaccinated after they accomplish this age (the minimum interval of 14 days between two vaccinations must be respected). The animals first vaccinated at the age of 3 to 12 months must be re-vaccinated one year after the first application of the vaccine. The re-vaccination performed one year after the first vaccination shall protect the animals from rabies for a minimum period of 2 years. To retain immunity, next re-vaccination is recommended pursuant to the veterinary regulations of the individual countries.
Method of administration and dosage:
The dose is 1 ml, regardless of age, weight and race of the individual. To be applied from the 12th week of age.
Method of administration:
- subcutaneously, preferably behind the shoulder blade.
- intramuscularly, preferably to the muscles of the pelvic limb.
Contact the seller
Biocan R vaccine
We recommend to see